Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular Atrial Fibrillation
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 91
- 试验地点
- 8
- 主要终点
- Comparison of subjective stroke risk perception with CHA2DS2-VASc score
研究概览
简要总结
The risk of stroke is markedly elevated in patients with atrial fibrillation (AF). Oral anticoagulation (OAC) is indicated in individuals with moderate and high risk of stroke to the disadvantage of an increased burden from bleeding. Adequate knowledge of this disorder and understanding the benefits and hazards of antithrombotic treatment are essential to incorporate patient´s values and preferences in these decisions. This will further improve acceptance of recommended therapy and augment compliance with OAC.
The objective of this investigation is to compare patient´s perceptions and physician´s assessments of benefits and risks of OAC.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed and ECG-documented non-valvular atrial fibrillation
- •New indication for oral anticoagulation (OAC)
- •Ability of informed consent
排除标准
- •Existing OAC therapy
- •Valvular heart disease
- •History of valve surgery
结局指标
主要结局
Comparison of subjective stroke risk perception with CHA2DS2-VASc score
时间窗: Baseline
Comparison of subjective bleeding risk perception with HAS-BLED score
时间窗: Baseline
次要结局
- Relationship between accurate perception of stroke and bleeding risks and baseline parameters (highest completed level of education, subjective level of information)(Baseline)